Dr. Ananthakumar Thillainathan

One of the most prevalent nosocomial infections, surgical site infections (SSIs), are known to cause severe morbidity. They lead to more hospital stays, shorter lifetimes, more procedures for patients, and higher healthcare expenses. Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and third-generation cephalosporin-resistant Escherichia coli are only a few of the microorganisms that can cause SSIs. Resistant germs can significantly impact the safety and results of patients. An unnecessary postoperative complication that raises patient morbidity and medical expenses is surgical site infection (SSI). The most frequent cause of SSIs is bacteria introduced into the surgical site from the patient's endogenous flora. SSIs sometimes referred to as superficial incisional SSIs (SISI), can develop at the surgical site. Deep incisional SSI, as they are also known, can develop in the muscles and tissues around the incision location. Using informatio...

Community-acquired pneumonia (CAP) is a common cause of death and disability among people living with HIV. CAP is a major public health problem worldwide and has a high mortality rate. The treatment of CAP depends on the type of pneumonia and the cause. For example, bacterial pneumonia requires antibiotics to treat the infection. Antimicrobial therapy is a key component of treatment for community-acquired pneumonia. It involves the use of empirically selected antibiotics that are rapidly started to reduce symptoms, minimize the duration of hospitalization, and prevent complications. The main goals of antibiotic treatment are to identify the pathogen and kill it. The decision to start antimicrobial therapy depends on the type of infection and its severity, as well as the pattern of local antibiotic resistance and other patient-specific factors. The most common pathogens in community-acquired pneumonia are Streptococcus pneumoniae, Haemophilus influenzae, and atypical bacteria such ...